Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Pharmos (PARS) -- Ignore unavailable to you. Want to Upgrade?

To: Rick Strange who wrote (423)	1/18/1999 3:26:00 PM
From: Cacaito	Respond to of 1386

Parsimoniously

To: Rick Strange who wrote (423)	1/21/1999 8:29:00 PM
From: crysball	Read Replies (1) \| Respond to of 1386

Breast Cancer ~ Dieldrin ~ Tamoxifen Rick in reply to your question. Lancet recently published a study by Danish Epidemiologist Dr. Annette Hoyer. The study was large and well designed, involving 7,712 wonen who had been followed for over 2 decades . It suggested a strong statistical link between breast cancer and those exposed to Dieldrin, an insecticide presently banned, but in the food chain, since it does not readily breakdown in the environment. Interestingly the study also examined other insecticides (such as DDT) and dod not find a statistically positive correlation. The study has reignited the debate over xeno-estrogens, or compounds which mimic estrogen's chemical structure, and their relation to certain estrogen dependent cancers (such as Breast Cancer). Xeno-estrogens are a broad class of compounds not just limited to insecticides (includes some petroleum compounds for example).